RTW Biotech Opportunities (LON:RTW – Get Free Report) shares traded down 3.5% during mid-day trading on Wednesday . The company traded as low as GBX 1.10 ($0.01) and last traded at GBX 1.10 ($0.01). 265,996 shares were traded during mid-day trading, an increase of 20% from the average session volume of 221,595 shares. The stock had previously closed at GBX 1.14 ($0.01).
RTW Biotech Opportunities Price Performance
The firm has a 50-day simple moving average of GBX 1.27 and a 200 day simple moving average of GBX 1.40. The stock has a market capitalization of £374.54 million, a P/E ratio of 2.66 and a beta of 0.60.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd (LSE: RTW or RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives.
See Also
- Five stocks we like better than RTW Biotech Opportunities
- Ride Out The Recession With These Dividend Kings
- JPMorgan is a Buy, if You Can Handle The Volatility
- Stock Market Sectors: What Are They and How Many Are There?
- United States Steel’s Crash: An Unmissable Buying Opportunity
- How to trade penny stocks: A step-by-step guide
- Rocket Lab Stock: Weathering the Storm, Time for a Comeback?
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
